BPC-157's side effect profile is a mystery at this point, because we just dont have any human trial data to refer back to at this point
Aberrant DNA methylation patterns have been identified in patients with HT, leading to gene silencing and altered expression of genes regulating the immune response, along with hypermethylation of specific CpG sites
doi:10.1016/j.mehy.2021.110736 [3] Veljaca M., Sladoljev D., Mildner B
That matters when your target dose is 2.5 mg, because a 0.6 mg error represents a 24% deviation from your intended dose
GHK-Cu is a copper-binding tripeptide used in laboratory research to study peptidecopper interactions, signaling pathways, and gene-expression responses in controlled experimental systems
Research classification: Selective growth hormone secretagogue (ghrelin receptor agonist)